Seven senators are questioning why Sanofi and AstraZeneca underestimated the demand for Beyfortus, the first pediatric drug approved for respiratory syncytial virus.
Seven senators are questioning why Sanofi and AstraZeneca underestimated the demand for Beyfortus, the first pediatric drug approved for respiratory syncytial virus.
Copyright © 2024 | WordPress Theme by MH Themes